Since EGFR and mTORC1 drive central mitogenic pathways in the cell and are frequently hyperactivated in human cancers, it is likely that their concomitant inhibition by THZ531 causes the strong repression of proliferation observed in our study. This evidence concerns the gene EGFR and cancer.